THINK Surgical Receives FDA 510(k) Clearance for MOBIO™ Knee System implants on TMINI® Miniature Robotic System

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

FREMONT, Calif., Nov. 20, 2024 /PRNewswire/ — THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced that its TMINI® Miniature Robotic System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use with the MOBIO Total Knee System from b-ONE Ortho Corporation (Cedar Knolls, NJ) under a Collaboration Agreement between the two companies.

The MOBIO Total Knee System has been added to THINK Surgical’s ID-HUB™, a proprietary data bank of implant modules for use with the open platform version of its TMINI System in the United States.

“THINK Surgical is excited to add the MOBIO Total Knee System to the TMINI System. The open platform version of TMINI is now available with eight different knee designs from eight separate orthopedic companies offering surgeons the choice of single-radius, anatomic, and guided motion knees on a single robotic platform.” said Stuart Simpson, president, and chief executive officer of THINK Surgical. 

“We are very enthusiastic about receiving this clearance for use with the THINK Surgical TMINI System platform, which not only enhances our MOBIO™ Total Knee System portfolio in offering our customers a robotic assisted technology solution, but it also provides b-ONE greater market penetrating strategic options and solutions. We look forward to this continued partnership with THINK Surgical offering a proven total knee design that can provide a smooth transition for many surgeons across the United States“, said Jim Duncan, General Manager of b-ONE Ortho Corporation. 

About THINK Surgical, Inc.

THINK Surgical, Inc., is a privately held U.S.-based technology innovator that develops and markets orthopedic robots.

THINK Surgical actively collaborates with healthcare professionals to refine our orthopedic products, improving the lives of those suffering from advanced joint disease with precise, accurate, and intelligent technology.  Please refer to the instructions for use for the TMINI Miniature Robotic System for a complete list of indications, contraindications, warnings, and precautions. For additional product information, please visit www.thinksurgical.com.  

THINK Surgical and TMINI are trademarks of THINK Surgical, Inc. 

About b-ONE Ortho Corporation

b-ONE Ortho is a Global Manufacturer based out of Cedar Knolls, New Jersey. We, at b-ONE, are committed to improving the experience of both patients and surgeons through innovative technologies. With our passion for advanced manufacturing, advanced material science, artificial intelligence, and robotics, we relentlessly pursue ways to offer best in class healthcare solutions while increasing healthcare economic value. Our goal is to help more patients worldwide to gain their active lifestyle back with the best means humankind ever created-innovative technology.

Media Contacts:

THINK Surgical                                                                   

b-ONE Ortho Corporation

Nick Margree                                                                         

Jim Duncan

nmargree@thinksurgical.com                                             

JDuncan@b1.co  

View original content to download multimedia:https://www.prnewswire.com/news-releases/think-surgical-receives-fda-510k-clearance-for-mobio-knee-system-implants-on-tmini-miniature-robotic-system-302308348.html

SOURCE THINK Surgical, Inc.

Staff

Recent Posts

Herbal Oasis Wins National Recognition at the 2025 High Spirits Awards

Charlotte, North Carolina--(Newsfile Corp. - April 24, 2025) - Herbal Oasis, a rising star in…

40 minutes ago

Personalized Aroma Recommendation Experience Using SOLO Wellbeing’s Facial Analysis AI Introduced at the “Wellness Lounge” Operated by NTT East, NTT Data, and Storyline

TEL AVIV, Israel, April 24, 2025 /PRNewswire/ -- SOLO Wellbeing Ltd. (Headquarter: Israel, CEO: Roy Tal,…

2 hours ago

Novo Holdings and EIFO invest €48 million in HealthCap IX to strengthen the Nordic life sciences ecosystem

COPENHAGEN, Denmark, April 24, 2025 /PRNewswire/ -- Novo Holdings and the Export and Investment Fund…

2 hours ago

ACTO and ScienceMedia Partner to Enhance Clinical Competency and Confidence for Life Sciences Field Teams

AI-powered, on-demand access to clinical content enhances HCP interactions and drives measurable commercial impact for…

2 hours ago

Former Nike VP & GM Bert Hoyt Joins dBio to Drive Next-Gen Sports & Health Tech as Board Advisor

LUXEMBOURG, April 23, 2025 /PRNewswire/ -- Decentralized Biotechnology Intelligence Holding Group Inc. (dBio), a leading…

8 hours ago

Labroots Open-Access Scientific Virtual Event Lineup: Spring 2025

YORBA LINDA, Calif., April 23, 2025 /PRNewswire/ -- Labroots, the leading scientific social networking website…

8 hours ago